Bhalla, Sheena http://orcid.org/0000-0003-0614-9546
Gerber, David E.
Funding for this research was provided by:
South Plains Oncology Consortium
University of Texas Lung Specialized Program in Research Excellence (P50CA070907-21)
Article History
Accepted: 21 February 2023
First Online: 15 March 2023
Declarations
:
: Sheena Bhalla has served in a consulting/advisory role for Takeda, Mirati. David Gerber has served in a consulting/advisory role for BeiGene, Catalyst, Daiichi-Sankyo, Elevation Oncology, Jansen, Mirati, Regeneron; is a shareholder in Gilead, OncoSeer Diagnostics, LLCĀ is co-founder of OncoSeer Diagnostics, LLC.
: This article does not contain any studies with human or animal subjects performed by any of the authors.